Cell News and Research

RSS

Experimental stem cell treatment improves vision in blind mice

An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.

3 Oct 2012

InterMune receives Health Canada approval for Esbriet to treat idiopathic pulmonary fibrosis

InterMune, Inc. today announced that Health Canada has approved Esbriet (pirfenidone) for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) in adult patients.

3 Oct 2012

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers--genetic characteristics that are associated with some patients with breast cancer--can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

3 Oct 2012

$Stent fracture after stent implantation linked to thrombosis$

Stent fracture after stent implantation linked to thrombosis

Stent fracture after everolimus-eluting stent implantation occurs in 2.9% of lesions and is associated with a significantly increased rate of major adverse cardiac events, say researchers.

2 Oct 2012

Mothers’ CD4 cells ‘remember’ their babies

A breakthrough in understanding a mother’s immune response during pregnancy suggests a new direction for treating autoimmune diseases.

2 Oct 2012

Research report helps explain how macrophages accumulate triglycerides

A research report appearing in the Journal of Leukocyte Biology helps explain how specific immune cells, called macrophages, accumulate triglycerides to support their function.

2 Oct 2012

Omega-3 fatty acid supplements could slow key biological process linked to aging

Taking enough omega-3 fatty acid supplements to change the balance of oils in the diet could slow a key biological process linked to aging, new research suggests.

2 Oct 2012

Novel therapy shows promise in treating multiple myeloma following stem cell transplants

A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets for the immune system.

2 Oct 2012

F-18-FLT-PET predicts early response to chemoradiotherapy in head and neck cancer

Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent.

2 Oct 2012

Toronto Rehab, Calgary Stroke Program receive Distinction status from Accreditation Canada

The Calgary Stroke Program continues to be one of the top stroke programs in Canada and today received a second "Stroke Services Distinction" award from Accreditation Canada. It remains the only comprehensive stroke program in the country with this status.

2 Oct 2012

Anemia now confirmed as risk factor for illness and even death following cardiac surgery

Anemia is now confirmed as a risk factor for illness and even death following cardiac surgery, according to a study published in the October 2012 issue of The Annals of Thoracic Surgery.

2 Oct 2012

OS data from ImmunoGen's trastuzumab emtansine Phase III trial on breast cancer

ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.

2 Oct 2012

Extended length pipette introduced by INTEGRA

INTEGRA has introduced a new extended length GripTip pipette tip available in non-sterile, sterile, filter and GREEN CHOICE configurations.

From INTEGRA Biosciences 2 Oct 2012

Incidence of esophageal, stomach cancers increased in AIDS

The risk for esophageal and stomach carcinomas, as well as non-Hodgkin lymphomas, is significantly increased in people with AIDS, although the incidence of lymphomas has decreased, the results of a US and UK study reveal.

1 Oct 2012

Prognosis still poor for EVB in cirrhosis

The current standard of care for esophageal variceal bleeding in liver cirrhosis is very effective at controlling bleeding but patient prognosis remains poor, say the authors of an Italian study.

1 Oct 2012

Multiple Epo doses with hypothermia offers neonate neuroprotection

Multiple doses of erythropoietin in combination with hypothermia could be neuroprotective in neonates with hypoxic‑ischemic encephalopathy, say researchers.

1 Oct 2012

New treatment target brings hope for scleroderma patients

Research presented at the European Academy of Dermatology and Venereology in Prague, Czech Republic, suggests that inhibition of the SMAD protein may be a viable therapeutic target in scleroderma patients.

1 Oct 2012

WBC counts in diabetes risk prediction

An elevated white blood cell count in young men is an independent predictor for the development of diabetes in later life, suggest study findings.

1 Oct 2012

Clinical need, effectiveness, fairness should drive drugs allocation

A policy that is transparent, fair to patients and healthcare providers, and is based on clinical need is an ethically justifiable approach to rationing drugs that are in critically short supply, report researchers.

1 Oct 2012

Addition of ficlatuzumab to gefitinib may be effective in select subsets of patients with NSCLC

AVEO Oncology today announced that detailed results from an exploratory, randomized Phase 2 study evaluating the combination of ficlatuzumab, the company's HGF inhibitory antibody, and gefitinib compared to gefitinib monotherapy in previously untreated Asian subjects with non-small cell lung cancer (NSCLC) were presented at the 2012 Congress of the European Society for Medical Oncology (ESMO).

1 Oct 2012

Cell News and Research

Experimental stem cell treatment improves vision in blind mice

InterMune receives Health Canada approval for Esbriet to treat idiopathic pulmonary fibrosis

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Stent fracture after stent implantation linked to thrombosis

Mothers’ CD4 cells ‘remember’ their babies

Research report helps explain how macrophages accumulate triglycerides

Omega-3 fatty acid supplements could slow key biological process linked to aging

Novel therapy shows promise in treating multiple myeloma following stem cell transplants

F-18-FLT-PET predicts early response to chemoradiotherapy in head and neck cancer

Toronto Rehab, Calgary Stroke Program receive Distinction status from Accreditation Canada

Anemia now confirmed as risk factor for illness and even death following cardiac surgery

OS data from ImmunoGen's trastuzumab emtansine Phase III trial on breast cancer

Extended length pipette introduced by INTEGRA

Incidence of esophageal, stomach cancers increased in AIDS

Prognosis still poor for EVB in cirrhosis

Multiple Epo doses with hypothermia offers neonate neuroprotection

New treatment target brings hope for scleroderma patients

WBC counts in diabetes risk prediction

Clinical need, effectiveness, fairness should drive drugs allocation

Addition of ficlatuzumab to gefitinib may be effective in select subsets of patients with NSCLC

How to optimize your cell line development eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News